Literature DB >> 33196100

Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib.

Xiangqian Li1, Xia Wu, Dirk M Elston, Jianzhong Zhang, Cheng Zhou.   

Abstract

Entities:  

Keywords:  JAK inhibitor; ectodysplasin A; hypohidrotic ectodermal dysplasia; tofacitinib; atopic dermatitis

Mesh：

Substances：

Year:  2021        PMID： 33196100      PMCID： PMC9309845          DOI： 10.2340/00015555-3693

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  14 in total

1.  Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate.

Authors:  Lauren L Levy; Jennifer Urban; Brett A King
Journal:  J Am Acad Dermatol       Date:  2015-07-17       Impact factor: 11.527

2.  Clinical aspects of X-linked hypohidrotic ectodermal dysplasia.

Authors:  A Clarke; D I Phillips; R Brown; P S Harper
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

3.  Hypohidrotic ectodermal dysplasia: A report of two cases.

Authors:  Tomomi Miyake; Yukiko Kiniwa; Tomoki Kosho; Hajime Nakano; Ryuhei Okuyama
Journal:  J Dermatol       Date:  2016-06-06       Impact factor: 4.005

4.  The prevalence of X-linked hypohidrotic ectodermal dysplasia (XLHED) in Denmark, 1995-2010.

Authors:  Mary Nguyen-Nielsen; Stine Skovbo; Dea Svaneby; Lars Pedersen; Jon Fryzek
Journal:  Eur J Med Genet       Date:  2013-02-14       Impact factor: 2.708

Review 5.  Unraveling the Link Between Ectodermal Disorders and Primary Immunodeficiencies.

Authors:  Roberta D'Assante; Anna Fusco; Loredana Palamaro; Giuliana Giardino; Vera Gallo; Emilia Cirillo; Claudio Pignata
Journal:  Int Rev Immunol       Date:  2015-03-16       Impact factor: 5.311

6.  Novel EDA mutation in X-linked hypohidrotic ectodermal dysplasia and genotype-phenotype correlation.

Authors:  B Zeng; H Lu; X Xiao; L Zhou; J Lu; L Zhu; D Yu; W Zhao
Journal:  Oral Dis       Date:  2015-10-24       Impact factor: 3.511

7.  Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.

Authors:  Emma Guttman-Yassky; Jonathan I Silverberg; Osamu Nemoto; Seth B Forman; August Wilke; Randy Prescilla; Amparo de la Peña; Fabio P Nunes; Jonathan Janes; Margaret Gamalo; David Donley; Jim Paik; Amy M DeLozier; Brian J Nickoloff; Eric L Simpson
Journal:  J Am Acad Dermatol       Date:  2018-02-02       Impact factor: 11.527

Review 8.  Molecular basis of hypohidrotic ectodermal dysplasia: an update.

Authors:  Wieslaw H Trzeciak; Ryszard Koczorowski
Journal:  J Appl Genet       Date:  2015-08-21       Impact factor: 3.240

9.  Hereditary ectodermal dysplasia: A retrospective study.

Authors:  Chandramani B More; Khusbhu Bhavsar; Jigar Joshi; Saurabh N Varma; Mansi Tailor
Journal:  J Nat Sci Biol Med       Date:  2013-07

10.  Pathogenic EDA Mutations in Chinese Han Families With Hypohidrotic Ectodermal Dysplasia and Genotype-Phenotype: A Correlation Analysis.

Authors:  Yang Han; Xiuli Wang; Liyun Zheng; Tingting Zhu; Yuwei Li; Jiaqi Hong; Congcong Xu; Peiguang Wang; Min Gao
Journal:  Front Genet       Date:  2020-02-04       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.